Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib + FOLFOX +/- Bevacizumab in mCRC
NCT00460603Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2006
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in metastatic colorectal cancer (mCRC), sponsored by Pfizer. Started Jan 2006; status: completed.
02
Drugs
axitinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00460603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460603.